NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Major histocompatibility complex (MHC) molecules are expressed on the cell surface, where they present peptides to T cells, which gives them a key role in the development of T-cell immune responses. MHC molecules come in two main variants: MHC Class I (MHC-I) and MHC Class II (MHC-II). MHC-I predominantly present peptides derived from intracellular proteins, whereas MHC-II predominantly presents peptides from extracellular proteins. In both cases, the binding between MHC and antigenic peptides is the most selective step in the antigen presentation pathway. Therefore, the prediction of peptide binding to MHC is a powerful utility to predict the possible specificity of a T-cell immune response. Commonly MHC binding prediction tools are trained on binding affinity or mass spectrometry-eluted ligands. Recent studies have however demonstrated how the integration of both data types can boost predictive performances. Inspired by this, we here present NetMHCpan-4.1 and NetMHCIIpan-4.0, two web servers created to predict binding between peptides and MHC-I and MHC-II, respectively. Both methods exploit tailored machine learning strategies to integrate different training data types, resulting in state-of-the-art performance and outperforming their competitors. The servers are available at http://www.cbs.dtu.dk/services/NetMHCpan-4.1/ and http://www.cbs.dtu.dk/services/NetMHCIIpan-4.0/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these tools, NetMHCpan stands out in predicting the binding affinity between peptides and MHC-I/II, respectively [139].”
From Single-cell sequencing to multi-omics: technologies and applications (2024) · cites this paper as [139]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jurtz, V., Paul, S., Andreatta, M., Marcatili, P., Peters, B., & Nielsen, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700893 · Cited by 1,470
Self-citationImproved methods for predicting peptide binding affinity to MHC class II molecules
Jensen, K. K., Andreatta, M., Marcatili, P., Buus, S., Greenbaum, J. A., Yan, Z., Sette, A., Peters, B., & Nielsen, M. (2018) · Immunology · doi:10.1111/imm.12889 · Cited by 794
Self-citationAbelin, J. G., Keskin, D. B., Sarkizova, S., Hartigan, C. R., Zhang, W., Sidney, J., Stevens, J., Lane, W., Zhang, G. L., Eisenhaure, T. M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.007 · Cited by 617
Nielsen, M., & Andreatta, M. (2016) · Genome Medicine · doi:10.1186/s13073-016-0288-x · Cited by 517
Self-citationSarkizova, S., Klaeger, S., Le, P. M., Li, L. W., Oliveira, G., Keshishian, H., Hartigan, C. R., Zhang, W., Braun, D. A., Ligon, K. L., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0322-9 · Cited by 499
Reynisson, B., Barra, C., Kaabinejadian, S., Hildebrand, W. H., Peters, B., & Nielsen, M. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00874 · Cited by 445
Self-citationMHCflurry: Open-Source Class I MHC Binding Affinity Prediction
O'Donnell, T. J., Rubinsteyn, A., Bonsack, M., Riemer, A. B., Laserson, U., & Hammerbacher, J. (2018) · Cell Systems · doi:10.1016/j.cels.2018.05.014 · Cited by 409
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
Bulik-Sullivan, B., Busby, J., Palmer, C. D., Davis, M. J., Murphy, T., Clark, A., Busby, M., Duke, F., Yang, A., Young, L., et al. (2019) · Nature Biotechnology · doi:10.1038/nbt.4313 · Cited by 307
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes
Racle, J., Michaux, J., Rockinger, G. A., Arnaud, M., Bobisse, S., Chong, C., Guillaume, P., Coukos, G., Harari, A., Jandus, C., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0289-6 · Cited by 289
Karosiene, E., Rasmussen, M., Blicher, T., Lund, O., Buus, S., & Nielsen, M. (2013) · Immunogenetics · doi:10.1007/s00251-013-0720-y · Cited by 272
Self-citation
Research works printed but not linked: 1
- O’Donnell T.J., Rubinsteyn A., Bonsack M., Riemer A.B., Laserson U., Hammerbacher J. 2020; MHCFlurry https://github.com/openvax/mhcflurry. 29960884
Cited by
Items 501–600 of 1,014
Chen, P., Chen, D., Bu, D., Gao, J., Qin, W., Deng, K., Ren, L., She, S., Xu, W., Yao, Y., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006334 · Cited by 20
Chemical complexity challenge: Is multi‐instance machine learning a solution?
Zankov, D. V., Madzhidov, T., Varnek, A. A., & Полищук, П. Г. (2023) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1698 · Cited by 20
Cross-Reactivity Assessment of Vaccine-Derived SARS-CoV-2 T Cell Responses against BA.2.86 and JN.1
Sohail, M. S., Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2024) · Viruses · doi:10.3390/v16030473 · Cited by 20
Ge, J., Jiang, D., Sun, H., Kang, Y., Pan, P., Deng, Y., Hsieh, C., & Hou, T. (2024) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2024.101980 · Cited by 20
Comparison of “framework Shuffling” and “CDR Grafting” in humanization of a PD-1 murine antibody
Wang, Y., Chen, Y., Xu, H., Rana, G. E., Tan, X., He, M., Jing, Q., Wang, Q., Wang, G., Xie, Z., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1395854 · Cited by 20
An, W., Li, T., Tian, X., Fu, X., Li, C., Wang, Z., Wang, J., & Wang, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910520 · Cited by 20
Case, J. B., Sanapala, S., Dillen, C. A., Rhodes, V., Zmasek, C. M., Chicz, T. M., Switzer, C., Scheaffer, S. M., Georgiev, G. P., Jacob-Dolan, C., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.10.016 · Cited by 20
Kochavi, A., Nagel, R., Körner, P.-R., Bleijerveld, O. B., Lin, C., Huinen, Z. R., Malka, Y., Proost, N., van de Ven, M., Feng, X., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1110 · Cited by 20
Epitope mapping via in vitro deep mutational scanning methods and its applications
Keen, M. M., Keith, A. D., & Ortlund, E. A. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108072 · Cited by 20
Attermann, A. S., Barra, C., Reynisson, B., Schultz, H. S., Leurs, U., Lamberth, K., & Nielsen, M. (2020) · Immunology · doi:10.1111/imm.13274 · Cited by 20
Self-citationCSPG4 Is a Potential Therapeutic Target in Anaplastic Thyroid Cancer
Egan, C. E., Stefanova, D. I., Ahmed, A., Raja, V. J., Thiesmeyer, J. W., Chen, K. J., Greenberg, J. A., Zhang, T., He, B., Finnerty, B. M., et al. (2021) · Thyroid · doi:10.1089/thy.2021.0067 · Cited by 20
Unique Pathogen Peptidomes Facilitate Pathogen-Specific Selection and Specialization of MHC Alleles
Özer, O., & Lenz, T. L. (2021) · Molecular Biology and Evolution · doi:10.1093/molbev/msab176 · Cited by 20
Antitumor Peptide-Based Vaccine in the Limelight
Kumai, T., Yamaki, H., Kono, M., Hayashi, R., Wakisaka, R., & Komatsuda, H. (2022) · Vaccines · doi:10.3390/vaccines10010070 · Cited by 21
Bagherzadeh, M. A., Izadi, M., Baesi, K., Jahromi, M. A. M., & Pirestani, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-18152-5 · Cited by 20
Cormican, J. A., Horokhovskyi, Y., Soh, W. T., Mishto, M., & Liepe, J. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100432 · Cited by 20
Clonal diversity predicts persistence of SARS-CoV-2 epitope-specific T-cell response
Zornikova, K. V., Khmelevskaya, A. A., Sheetikov, S. A., Kiryukhin, D. O., Shcherbakova, O. V., Titov, A., Zvyagin, I. V., & Efimov, G. A. (2022) · Communications Biology · doi:10.1038/s42003-022-04250-7 · Cited by 20
Attentive Variational Information Bottleneck for TCR–peptide interaction prediction
Grazioli, F., Machart, P., Mösch, A., Li, K., Castorina, L. V., Pfeifer, N., & Min, M. R. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac820 · Cited by 20
Wang, G., Mudgal, P., Wang, L., Shuen, T. W. H., Wu, H., Alexander, P. B., Wang, W.-W., Wan, Y., Toh, H. C., Wang, X., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1955545 · Cited by 20
Barua, H., Hasan, M. R., Mardiya, R. T., Shishir, T. A., Hossain, H., Azam, F. M. S., Akhand, M. R. N., & Mashrur, M. N. (2025) · Vacunas (English Edition) · doi:10.1016/j.vacune.2026.500490 · Cited by 19
Beg, A. Z., Farhat, N., & Khan, A. U. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104982 · Cited by 19
Integrating immunopeptidome analysis for the design and development of cancer vaccines
Feola, S., Chiaro, J., & Cerullo, V. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101750 · Cited by 19
Becerra‐Artiles, A., Nanaware, P. P., Muneeruddin, K., Weaver, G. C., Shaffer, S. A., Calvo‐Calle, J. M., & Stern, L. J. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011032 · Cited by 19
FusionNeoAntigen: a resource of fusion gene-specific neoantigens
Kumar, H., Luo, R., Wen, J., Yang, C., Zhou, X., & Kim, P. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad922 · Cited by 19
A large-scale study of peptide features defining immunogenicity of cancer neo-epitopes
Wan, Y.-T. R., Koşaloğlu‐Yalçın, Z., Peters, B., & Nielsen, M. (2024) · NAR Cancer · doi:10.1093/narcan/zcae002 · Cited by 19
Self-citationYang, Q., Xu, L., Dong, W., Li, X., Wang, K., Dong, S., Zhang, X., Yang, T., Jiang, F., Zhang, B., et al. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae302 · Cited by 19
Kortleve, D., Hammerl, D., van Brakel, M., Wijers, R., Roelofs, D., Kroese, K., Timmermans, M. M., Liao, C., Huang, S., Trapman-Jansen, A., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0168 · Cited by 20
Identification of immunogenic HLA class I and II neoantigens using surrogate immunopeptidomes
Tokita, S., Fusagawa, M., Matsumoto, S., Mariya, T., Umemoto, M., Hirohashi, Y., Hata, F., Saito, T., Kanaseki, T., & Torigoe, T. (2024) · Science Advances · doi:10.1126/sciadv.ado6491 · Cited by 19
Chuang, C.-C., Liu, Y., & Ou, Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136252 · Cited by 19
Integrated in-silico design and in vivo validation of multi-epitope vaccines for norovirus
Qiu, J., Wei, Y., Shu, J., Zheng, W., Zhang, Y., Xie, J., Zhang, D., Luo, X., Sun, X., Wang, X., et al. (2025) · Virology Journal · doi:10.1186/s12985-025-02796-6 · Cited by 19
Banerjee, A., Pattinson, D., Wincek, C. L., Bunk, P., Axhemi, A. A., Chapin, S. R., Navlakha, S., & Meyer, H. V. (2024) · Cell Systems · doi:10.1016/j.cels.2025.101345 · Cited by 19
Omondi, F. H., Sudderuddin, H., Shahid, A., Kinloch, N. N., Jones, B. R., Miller, R. L., Tsai, O., MacMillan, D., Piechocka‐Trocha, A., Brockman, M. A., et al. (2021) · mBio · doi:10.1128/mbio.02490-21 · Cited by 19
What’s next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination
Redwood, A., Dick, I. M., Creaney, J., & Robinson, B. W. S. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2038403 · Cited by 19
Sankaranarayanan, S., Mohkhedkar, M., & Vani, J. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166432 · Cited by 19
Machine learning‐based peptide‐spectrum match rescoring opens up the immunopeptidome
Adams, C., Laukens, K., Bittremieux, W., & Boonen, K. (2023) · PROTEOMICS · doi:10.1002/pmic.202300336 · Cited by 19
Copley, H. C., Gragert, L. A., Leach, A. R., & Kosmoliaptsis, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669357 · Cited by 19
Geometric deep learning improves generalizability of MHC-bound peptide predictions
(2024) · doi:10.1038/s42003-024-07292-1 · Cited by 18
Ge, J., Wang, J., Ye, Q., Pan, L., Kang, Y., Shen, C., Deng, Y., Hsieh, C., & Hou, T. (2025) · Chemical Science · doi:10.1039/d4sc08141b · Cited by 18
Zhao, X., Liu, Z., & Wu, C. (2025) · Integrative Medicine in Nephrology and Andrology · doi:10.1097/imna-d-25-00007 · Cited by 18
Personalized Cancer Vaccines: Current Advances and Emerging Horizons
Lu, L., Lu, X., & Luo, W. (2025) · Vaccines · doi:10.3390/vaccines13121231 · Cited by 18
Foster, K. A., Rees, E., Ainley, L., Laidler, A., Boyle, E. M., Lee, L. S. H., Ward, G., Galas‐Filipowicz, D., Fitzsimons, E., Mikolajczak, A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68718-4 · Cited by 18
McInnis, C. M., Bhatia, S., Vijaykumar, B., Tian, Q., Sun, Y., Leistritz-Edwards, D., Quinn, C. T., Uppaluri, R., Egloff, A. M., Srinivasan, L., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-006721 · Cited by 18
Carri, I., Schwab, E., Podaza, E., Alvarez, H. M. G., Mordoh, J., Nielsen, M., & Barrio, M. M. (2023) · Exploration of Immunology · doi:10.37349/ei.2023.00091 · Cited by 18
Self-citationImprovement in neoantigen prediction via integration of RNA sequencing data for variant calling
Nguyen, B. Q. T., Tran, T. P. D., Nguyen, H. T., Nguyễn, T. N., Pham, T. M. Q., Nguyen, H. T. P., Tran, D. H., Nguyen, V. T. T., Tran, T. S., Pham, T.-V. N., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1251603 · Cited by 18
Rational immunosilencing of a promiscuous T-cell epitope in the capsid of an adeno-associated virus
Bing, S. J., Seirup, M., Hoang, T. T., Najera, S. S., Britten, C. N., Warrington, S., Chu, S.-L., & Mazor, R. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01129-8 · Cited by 18
Wang, Y., Wu, A., Xu, Z., Zhang, H., Li, H., Fu, S., Liu, Y., Cui, L., Miao, Y., Wang, Y., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111351 · Cited by 18
Fasoulis, R., Rigo, M., Lizee, G. A., Antunes, D. A., & Kavraki, L. E. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01667 · Cited by 18
Fuchs, K. J., van de Meent, M., Honders, M. W., Khatri, I., Kester, M. G. D., Koster, E. A. S., Koutsoumpli, G., de Ru, A. H., van Bergen, C. A. M., van Veelen, P. A., et al. (2024) · Blood · doi:10.1182/blood.2023022343 · Cited by 18
Martínez, D., Fang, L., Meza-Torres, C., Garavito, G., López‐Lluch, G., & Egea, E. (2024) · Biomedicines · doi:10.3390/biomedicines12040884 · Cited by 18
Tan, C., Xiao, Y., Liu, T., Chen, S., Zhou, J., Zhang, S., Hu, Y., Wu, A., & Li, C. (2024) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2024.05.008 · Cited by 18
Skadborg, S. K., Maarup, S. B., Draghi, A., Borch, A., Hendriksen, S., Mundt, F., Pedersen, V., Mann, M., Christensen, I. J., Skjøth-Ramussen, J., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0959 · Cited by 18
A modular protein language modelling approach to immunogenicity prediction
O’Brien, H., Salm, M., Morton, L. T., Szukszto, M. J., O’Farrell, F., Boulton, C., King, L., Bola, S. K., Becker, P. D., Craig, A., et al. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012511 · Cited by 18
Self-citationProtPipe: A Multifunctional Data Analysis Pipeline for Proteomics and Peptidomics
Li, Z., Weller, C. A., Shah, S. I., Johnson, N. L., Hao, Y., Jarreau, P., Roberts, J. P., Guha, D., Bereda, C., Klaisner, S., et al. (2024) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzae083 · Cited by 18
Autoimmune-Like Mechanism in Heart Failure Enables Preventive Vaccine Therapy
Martini, E., Cremonesi, M., Felicetta, A., Serio, S., Puccio, S., Pelamatti, E., van Beek, J. J. P., Papadopoulou, V., Catalano, C., Fanuele, F., et al. (2024) · Circulation Research · doi:10.1161/circresaha.124.324999 · Cited by 18
From Bench to Bedside: Emerging Paradigms in CAR‐T Cell Therapy for Solid Malignancies
Chen, Y., Ren, R., Yan, L., Zhou, Y., Sun, R., Song, H., Yan, H., & Li, Y. (2025) · Advanced Science · doi:10.1002/advs.202505822 · Cited by 18
Ramarathinam, S. H., Ho, B. K., Dudek, N. L., & Purcell, A. W. (2021) · PROTEOMICS · doi:10.1002/pmic.202000160 · Cited by 17
HLA repertoire of 115 UAE nationals infected with SARS-CoV-2
Alnaqbi, H., Tay, G. K., Jelinek, H. F., Francis, A., Alefishat, E. A., Chehadeh, S. E. H., Saeed, A. T., Hussein, M. M., Salameh, L. I. J., Mahboub, B. H., et al. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.08.012 · Cited by 18
Codon usage studies and epitope-based peptide vaccine prediction against Tropheryma whipplei
Joshi, A., Krishnan, S., & Kaushik, V. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-022-00324-5 · Cited by 18
Clonal evolution and TCR specificity of the human T FH cell response to Plasmodium falciparum CSP
Wahl, I., Obraztsova, A., Puchan, J., Hundsdorfer, R., Chakravarty, S., Sim, B. K. L., Hoffman, S. L., Kremsner, P. G., Mordmüller, B. G., & Wardemann, H. (2022) · Science Immunology · doi:10.1126/sciimmunol.abm9644 · Cited by 18
Chiaro, J., Antignani, G., Feola, S., Feodoroff, M., Martins, B., Cojoc, H., Russo, S., Fusciello, M., Hamdan, F., Ferrari, V., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42668-7 · Cited by 18
Cai, Y., Li, D., Lv, D., Yu, J., Ma, Y., Jiang, T., Ding, N., Liu, Z., Li, Y., & Xu, J. (2024) · Scientific Data · doi:10.1038/s41597-024-03660-y · Cited by 18
TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors
Eggebø, M. S., Heinzelbecker, J., Palashati, H., Chandler, N., Tran, T. T., Li, Y., Yang, W., Laos, M., Blaas, I., Rustad, E. H., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02252-1 · Cited by 17
Self-citationHarnessing TCR repertoires: predictive insights and therapeutic monitoring in cancer immunotherapy
Chiffelle, J., Genolet, R., Michielin, O. A., & Harari, A. (2025) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2025.101076 · Cited by 17
In-silico epitope-based vaccines design: progress, challenges and the road ahead
Cernuto, F., Maleki, A., Russo, G. L., Salvatore, V. D., & Pappalardo, F. (2025) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2025.2599178 · Cited by 17
Ciacchi, L., van de Garde, M. D. B., Ladell, K., Farenc, C., Poelen, M. C. M., Miners, K. L., Llerena, C., Reid, H. H., Petersen, J., Price, D. A., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.03.020 · Cited by 17
Almazán, N. M., Rahbar, A., Carlsson, M., Hoffman, T., Kolstad, L., Rönnberg, B. J., Pantalone, M. R., Lewensohn‐Fuchs, I., Nauclér, A., Ohlin, M., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108441 · Cited by 17
Instability of the HLA-E peptidome of HIV presents a major barrier to therapeutic targeting
Wallace, Z., Heunis, T. D. J., Paterson, R. L., Suckling, R. J., Grant, T., Dembek, M., Donoso, J., Brener, J., Long, J., Bunjobpol, W., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.01.010 · Cited by 17
Weber, J. K., Morrone, J. A., Kang, S.-G., Zhang, L., Lang, L., Chowell, D., Krishna, C., Huynh, T., Parthasarathy, P. B., Luan, B., et al. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad504 · Cited by 17
Wang, M., Lei, C., Wang, J., Li, Y., & Li, M. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae154 · Cited by 17
Andrade, T. E. G., Peña, M. S., Fiorotti, J., Bin, R. D. S., Caetano, A. R., Connelley, T., & Santos, I. K. F. D. M. (2024) · Journal of Dairy Science · doi:10.3168/jds.2023-24628 · Cited by 17
VacSol-ML(ESKAPE): Machine learning empowering vaccine antigen prediction for ESKAPE pathogens
Nasir, S., Anwer, F., Ishaq, Z., Saeed, M. T., & Ali, A. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126204 · Cited by 17
Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy
Ren, Y., Yue, Y., Li, X., Weng, S., Xu, H., Liu, L., Cheng, Q., Luo, P., Zhang, T., Liu, Z., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113147 · Cited by 17
Mahdeen, A. A., Hossain, I., Masum, M. H. U., Islam, M. S., & Rabbi, T. M. F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0312239 · Cited by 17
Bullock, C. B., Wang, L., Ware, B. C., Wagoner, N., Ohara, R. A., Liu, T., Desai, P., Peters, B., MURPHY, K. M. M., Handley, S. A., et al. (2024) · mBio · doi:10.1128/mbio.02930-24 · Cited by 17
Self-citationXu, L., Yang, Q., Dong, W., Li, X., Wang, K., Dong, S., Zhang, X., Yang, T., Luo, G., Liao, X., et al. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae625 · Cited by 17
Carri, I., Schwab, E., Triviño, J. C., von Euw, E. M., Nielsen, M., Mordoh, J., & Barrio, M. M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1496204 · Cited by 17
Self-citationLemke, S., Dubbelaar, M. L., Zimmermann, P., Bauer, J., Nelde, A., Gravel, N. H., Scheid, J., Wacker, M., Jung, S., Dengler, A., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-011366 · Cited by 17
Artificial Intelligence and the Evolving Landscape of Immunopeptidomics
Vo, T. H., McNeela, E. A., O’Donovan, Ó., Rani, S., & Mehta, J. P. (2025) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.70018 · Cited by 17
ImmunoStruct enables multimodal deep learning for immunogenicity prediction
Givechian, K. B., Rocha, J. F., Liu, C., Yang, E., Tyagi, S., Greene, K., Ying, R., Caron, É., Iwasaki, A., & Krishnaswamy, S. (2025) · Nature Machine Intelligence · doi:10.1038/s42256-025-01163-y · Cited by 18
Charonis, S. A., Tsilibary, E.-P. C., & Georgopoulos, A. P. (2021) · Exploration of Immunology · doi:10.37349/ei.2021.00003 · Cited by 17
In Vitro Immunogenicity Prediction: Bridging between Innate and Adaptive Immunity
Cohen, S., & Chung, S. (2021) · Bioanalysis · doi:10.4155/bio-2021-0077 · Cited by 17
Wennink, R. A. W., de Boer, J. H., Hiddingh, S., Haasnoot, A. J. W., Ayuso, V. K., de Hoop, T. A., van Setten, J., Spierings, E., & Kuiper, J. J. W. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.9.19 · Cited by 17
Connecting MHC-I-binding motifs with HLA alleles via deep learning
Lee, K.-H., Chang, Y., Chen, T.-F., Juan, H., Tsai, H., & Chen, C. (2021) · Communications Biology · doi:10.1038/s42003-021-02716-8 · Cited by 17
3pHLA-score improves structure-based peptide-HLA binding affinity prediction
Conev, A., Devaurs, D., Rigo, M., Antunes, D. A., & Kavraki, L. E. (2022) · Scientific Reports · doi:10.1038/s41598-022-14526-x · Cited by 17
Jakhmola, S., Sk, M. F., Chatterjee, A., Jain, K., Kar, P., & Jha, H. C. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105856 · Cited by 17
Rcheulishvili, N., Mao, J., Papukashvili, D., Feng, S., Liu, C., Wang, X., He, Y., & Wang, P. G. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1203355 · Cited by 17
Shinkawa, T., Tokita, S., Nakatsugawa, M., Kikuchi, Y., Kanaseki, T., & Torigoe, T. (2021) · OncoImmunology · doi:10.1080/2162402x.2020.1870062 · Cited by 17
Human herpesvirus diversity is altered in HLA class I binding peptides
Palmer, W. H., Telford, M., Navarro, A., Santpere, G., & Norman, P. J. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123248119 · Cited by 16
A novel integrated approach to predicting cancer immunotherapy efficacy
Luo, R., Chyr, J., Wen, J., Wang, Y., Zhao, W., & Zhou, X. (2022) · Oncogene · doi:10.1038/s41388-023-02670-1 · Cited by 16
Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics
Wacker, M., Bauer, J., Wessling, L., Dubbelaar, M. L., Nelde, A., Rammensee, H., & Walz, J. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1219720 · Cited by 16
Erez, N., Achdout, H., Yahalom-Ronen, Y., Adutler‐Lieber, S., Bar‐On, L., Bar‐Haim, E., Politi, B., Vitner, E. B., Tamir, H., Melamed, S., et al. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45100502 · Cited by 16
Briercheck, E. L., Ravishankar, S., Ahmed, E. H., Alvarado, C. C. C., Barrios-Menéndez, J. C., Silva, O., Solórzano, E., Tala, M. M. S., Stevenson, P. A., Xu, Y., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023012461 · Cited by 16
Salek, M., Förster, J. D., Becker, J. P., Meyer, M., Charoentong, P., Lyu, Y., Lindner, K. A. M., Lotsch, C., Volkmar, M., Momburg, F., et al. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100825 · Cited by 16
Ali, S. L., Ali, A., Ullah, W., Khan, A., Khatrawi, E. M., Malik, A., Abduldayeva, A. A., Baiduissenova, A., Althagafi, H. J., & Fallatah, D. I. (2024) · Molecular Systems Design & Engineering · doi:10.1039/d3me00192j · Cited by 16
Duraisamy, N., Khan, M. Y., Shah, A. U., ElAlaoui, R. N., Cherkaoui, M., & Hemida, M. G. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1468890 · Cited by 16
Masum, M. H. U., Mahdeen, A. A., Barua, L., Parvin, R., Heema, H. P., & Ferdous, J. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107098 · Cited by 16
Kovalchik, K. A., Hamelin, D. J., Kubiniok, P., Bourdin, B., Mostefai, F., Poujol, R., Paré, B., Simpson, S. M., Sidney, J., Bonneil, É., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54734-9 · Cited by 16
Helicobacter pylori-targeted AI-driven vaccines: a paradigm shift in gastric cancer prevention
Tu, Z., Wang, Y., Liang, J., & Liu, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1500921 · Cited by 16
Ehsasatvatan, M., & Kohnehrouz, B. B. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311351 · Cited by 16
Large-scale transcript variants dictate neoepitopes for cancer immunotherapy
Ji, S., Wang, F., Wu, Y., Hu, H., Xing, Z., Zhu, J., Xu, S., Han, T., Liu, G., Wu, Z., et al. (2025) · Science Advances · doi:10.1126/sciadv.ado5600 · Cited by 16
Machine-Guided Dual-Objective Protein Engineering for Deimmunization and Therapeutic Functions
Wolfsberg, E., Paul, J.-S., Tycko, J., Chen, B., Bassik, M. C., Bintu, L., Alizadeh, A. A., & Gao, X. J. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101299 · Cited by 16
Metadata
- Authors
- Reynisson, B., Alvarez, B., Paul, S., Peters, B., & Nielsen, M.
- Affiliations
- Technical University of Denmark (DK)
- National University of General San Martín (AR)
- La Jolla Institute for Immunology (US)
- Corresponding author
- Nielsen, Morten
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-14
- Volume
- 48
- Issue
- W1
- Pages
- W449-W454
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC7319546
- OpenAlex
- W3024570138
- Cited by
- 2,361
- References
- 26
- Citations by year
- 2026: 493 · 2025: 550 · 2024: 459 · 2023: 345 · 2022: 250 · 2021: 216 · 2020: 47
- FWCI
- 69.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, public-domain)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (75N93019C00001)
- EIT Health (19638)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
- Keywords
- MHC-peptide binding prediction, MHC class I, MHC class II, antigen presentation, NetMHCpan, machine learning, web server, T cell response
- MeSH terms
- Machine Learning, Histocompatibility Antigens Class II, Ligands, Peptides, Software, Histocompatibility Antigens Class I, Antigen Presentation, Amino Acid Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.